TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 26462765

Group type: EXPERIMENTAL
Intervention: Mucinex® 1200 mg (2 × 600 mg extended release tablets)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study: 23396496

Group type: EXPERIMENTAL
Intervention: LCω‐3PUFA (fish oil)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo (monounsaturated oil)
Number of subjects: 39
Study: 21468659

Group type: EXPERIMENTAL
Intervention: Peer Mentor condition
Number of subjects: 169
Study: 18378377

Group type: EXPERIMENTAL
Intervention: 38% silver diamine fluoride every 12 months
Number of subjects: 10

Group type: COMPARATOR
Intervention: 5% sodium fluoride varnish every 3 months
Number of subjects: 10
Study: 16929626

Group type: EXPERIMENTAL
Intervention: Deaf individuals (bilingual, nasal-breathing, bilingual, buccal-breathing, oralist, nasal-breathing)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Healthy volunteers (control group)
Number of subjects: 50
Study: 12716270

Group type: EXPERIMENTAL
Intervention: Divalproex sodium
Number of subjects: 120

Group type: COMPARATOR
Intervention: Olanzapine
Number of subjects: 120
Study: 11153591

Group type: EXPERIMENTAL
Intervention: 0.5 g alcohol x kg body weight consumed 90 min prior to sleep time
Number of subjects: 21

Group type: COMPARATOR
Intervention: Non-alcohol night (control)
Number of subjects: 21
Study: 9101212

Group type: EXPERIMENTAL
Intervention: Nilutamide 300 mg/day for 1 month and 150 mg thereafter
Number of subjects: 868

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 868
Study: 7968873

Group type: EXPERIMENTAL
Intervention: Chemotherapy
Number of subjects: 0
Study: 2442552

Group type: EXPERIMENTAL
Intervention: Lisinopril (20-80 mg/day)
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: Nifedipine (40-80 mg/day)
Number of subjects: 136
Study: 31600823

Group type: EXPERIMENTAL
Intervention: Potentially misclassified intrapartum stillbirths (180 out of 391 recorded intrapartum stillbirths) with FHS at admission and no resuscitation initiated after birth.
Number of subjects: 39562

Group type: EXPERIMENTAL
Intervention: Potentially misclassified intrapartum stillbirths (180) with FHS present 15 minutes before birth.
Number of subjects: 39562

Group type: EXPERIMENTAL
Intervention: Potentially misclassified intrapartum stillbirths (180) with complications during labor.
Number of subjects: 39562

Group type: EXPERIMENTAL
Intervention: Potentially misclassified intrapartum stillbirths (180) with birthweight less than 2500 g.
Number of subjects: 39562

Group type: EXPERIMENTAL
Intervention: Potentially misclassified intrapartum stillbirths (180) that were born preterm.
Number of subjects: 39562

Group type: COMPARATOR
Intervention: Low birthweight babies (compared to normal birthweight).
Number of subjects: 39562

Group type: COMPARATOR
Intervention: Preterm babies (compared to term babies).
Number of subjects: 39562
Study: 29914566

Group type: EXPERIMENTAL
Intervention: Socioemotional and material learning paradigm (SEMLA)
Number of subjects: 432

Group type: EXPERIMENTAL
Intervention: Individual, digitally implemented attention and math training paradigm (DIL)
Number of subjects: 432

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 432
Study: 27113628

Group type: EXPERIMENTAL
Intervention: Intradialytic resistance exercise for 8 weeks
Number of subjects: 13

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 13
Study: 24845171

Group type: EXPERIMENTAL
Intervention: Combination of oral 17β‐estradiol valerate and micronized progesterone (group 1, n=10)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Oral 17β‐estradiol valerate (group 2, n=10)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo (group 3, n=10)
Number of subjects: 30
Study: 22635020

Group type: EXPERIMENTAL
Intervention: Vaginal tampons releasing chlorhexidine
Number of subjects: 20

Group type: COMPARATOR
Intervention: Neutral tampons (placebo)
Number of subjects: 20
Study: 20121659

Group type: EXPERIMENTAL
Intervention: Fesoterodine 4 mg
Number of subjects: 1674

Group type: EXPERIMENTAL
Intervention: Fesoterodine 8 mg
Number of subjects: 1674

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1674
Study: 18928092

Group type: EXPERIMENTAL
Intervention: Suhuang Zhike Capsule (SZC), 3 capsules three times daily for 7 days
Number of subjects: 280

Group type: COMPARATOR
Intervention: Zhike Ningsuo Capsule (ZNC), 3 capsules three times daily for 7 days
Number of subjects: 280
Study: 16861715

Group type: EXPERIMENTAL
Intervention: Intubation within 2 hours of admission with cholinergic features
Number of subjects: 376

Group type: EXPERIMENTAL
Intervention: Intubation after 24 hours while conscious and without cholinergic features
Number of subjects: 376

Group type: EXPERIMENTAL
Intervention: Ventilation duration
Number of subjects: 376
Study: 12736566

Group type: EXPERIMENTAL
Intervention: Treatment B (FT + TAM 20 mg/day for 2 years)
Number of subjects: 428

Group type: COMPARATOR
Intervention: Treatment A (FT 600 mg/day for 2 years)
Number of subjects: 428
Study: 11138583

Group type: EXPERIMENTAL
Intervention: Isometric electrical stimulation training to both legs for 60 min, five times per week for 16 weeks
Number of subjects: 6

Group type: COMPARATOR
Intervention: Untrained (control) group
Number of subjects: 6
Study: 8969280

Group type: EXPERIMENTAL
Intervention: Diet P (32 g protein/d)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Diet B (50 g protein/d)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Diet M (10 mmol L-methionine/d)
Number of subjects: 6
Study: 1482268

Group type: EXPERIMENTAL
Intervention: verapamil 240 mg SR (V)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: nifedipine 20 mg SR (N)
Number of subjects: 31
Study: 4006378

Group type: EXPERIMENTAL
Intervention: Oral pseudoracemic verapamil (160 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Oral d‐verapamil (250 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Oral l‐verapamil (100 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Intravenous verapamil
Number of subjects: 0
Study: 29208509

Group type: EXPERIMENTAL
Intervention: Intraarticular catheter with elastomeric pump (ropivacaine+dexketoprofen)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Epidural catheter (ropivacaine)
Number of subjects: 0
Study: 27978944

Group type: EXPERIMENTAL
Intervention: Upstream antithrombotic treatment
Number of subjects: 13726

Group type: EXPERIMENTAL
Intervention: Patients who bled before angiography
Number of subjects: 13726

Group type: EXPERIMENTAL
Intervention: Bleeding before angiography
Number of subjects: 13726
Study: 24521771

Group type: EXPERIMENTAL
Intervention: tacrolimus extended-release (Astagraf XL)
Number of subjects: 638

Group type: EXPERIMENTAL
Intervention: tacrolimus (Prograf)
Number of subjects: 638

Group type: COMPARATOR
Intervention: cyclosporine (CsA)
Number of subjects: 638
Study: 24273568

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Allergen
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Placebo and Allergen
Number of subjects: 0
Study: 20693157

Group type: EXPERIMENTAL
Intervention: Lifibrol (600 mg/d)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Pravastatin (40 mg/d)
Number of subjects: 16
Study: 18404267

Group type: EXPERIMENTAL
Intervention: GRASE (Gradient and Spin-Echo) magnetic resonance imaging
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Turbo-spin-echo (TSE) magnetic resonance imaging
Number of subjects: 35

Group type: COMPARATOR
Intervention: Phantom test with GRASE
Number of subjects: 35
Study: 15842142

Group type: EXPERIMENTAL
Intervention: Ginkgo biloba extract 1 g, three times a day
Number of subjects: 45

Group type: COMPARATOR
Intervention: Prednisone 30 mg, once a day
Number of subjects: 45
Study: 12893151

Group type: EXPERIMENTAL
Intervention: Intra-articular drain
Number of subjects: 49

Group type: COMPARATOR
Intervention: No intra-articular drain
Number of subjects: 49
Study: 10582873

Group type: EXPERIMENTAL
Intervention: 600 mg of azithromycin daily for 6 weeks
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: 1,200 mg of azithromycin daily for 6 weeks
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Both dose groups (600 mg and 1,200 mg)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 88
Study: 8671379

Group type: EXPERIMENTAL
Intervention: High vaginal deposition of seminal fluid separated from the husband's ejaculate
Number of subjects: 319

Group type: COMPARATOR
Intervention: Normal saline solution (control group)
Number of subjects: 319

Group type: EXPERIMENTAL
Intervention: Non-participants with unregulated intercourse
Number of subjects: 319

Group type: EXPERIMENTAL
Intervention: High vaginal deposition of seminal fluid
Number of subjects: 319
Study: 1831017

Group type: EXPERIMENTAL
Intervention: 800 mg of oral ibuprofen preoperatively
Number of subjects: 30

Group type: COMPARATOR
Intervention: 75 micrograms of intravenous fentanyl intraoperatively
Number of subjects: 30
Study: 6120763

Group type: EXPERIMENTAL
Intervention: Lorazepam (4 to 10 mg IV)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Clonazepam (1 mg IV)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Both drugs
Number of subjects: 61
Study: 30295335

Group type: EXPERIMENTAL
Intervention: Crizanlizumab 5 mg/kg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Crizanlizumab
Number of subjects: 0
Study: 26895416

Group type: EXPERIMENTAL
Intervention: Strength of Cultural Affiliation Scale (SCAS)
Number of subjects: 604
Study: 27022111

Group type: EXPERIMENTAL
Intervention: Tamoxifen plus OFS
Number of subjects: 1722

Group type: COMPARATOR
Intervention: Tamoxifen alone
Number of subjects: 1722
Study: 25131223

Group type: EXPERIMENTAL
Intervention: Recombinant human cytotoxic T-lymphocyte-associated antigen-4 immunoglobulin (RhCTLA4-Ig)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Infliximab
Number of subjects: 56

Group type: COMPARATOR
Intervention: Methotrexate (MTX)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Biologics-treated groups (RhCTLA4-Ig and infliximab combined)
Number of subjects: 56
Study: 22423139

Group type: EXPERIMENTAL
Intervention: Trivalent inactivated influenza vaccine (TIV)
Number of subjects: 115
Study: 19318275

Group type: EXPERIMENTAL
Intervention: PVA+Inc
Number of subjects: 54

Group type: COMPARATOR
Intervention: PVA
Number of subjects: 54

Group type: COMPARATOR
Intervention: PVS
Number of subjects: 54
Study: 17631800

Group type: EXPERIMENTAL
Intervention: Yiqi Tongmai Oral Liquid (YQTM)
Number of subjects: 219

Group type: COMPARATOR
Intervention: Shuxin Oral Liquid (SX)
Number of subjects: 219
Study: 15675261

Group type: EXPERIMENTAL
Intervention: 4% articaine with 1:100,000 epinephrine
Number of subjects: 51

Group type: COMPARATOR
Intervention: 2% lidocaine with 1:100,000 epinephrine
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Both anesthetic solutions
Number of subjects: 51
Study: 12080400

Group type: EXPERIMENTAL
Intervention: alpha-tocopherol (50 mg/day)
Number of subjects: 26951

Group type: EXPERIMENTAL
Intervention: beta-carotene (20 mg/day)
Number of subjects: 26951

Group type: EXPERIMENTAL
Intervention: both alpha-tocopherol and beta-carotene
Number of subjects: 26951

Group type: EXPERIMENTAL
Intervention: dietary vitamin C or E, alpha- or gamma-tocopherol, retinol, alpha- or beta-carotene, lycopene or lutein+zeaxanthin
Number of subjects: 26951

Group type: EXPERIMENTAL
Intervention: serum alpha-tocopherol, beta-carotene or retinol
Number of subjects: 26951
Study: 9579716

Group type: EXPERIMENTAL
Intervention: roxithromycin 300 mg po od
Number of subjects: 60

Group type: COMPARATOR
Intervention: clarithromycin 500 mg po bd
Number of subjects: 60
Study: 7647378

Group type: EXPERIMENTAL
Intervention: PRP+ (n = 64)
Number of subjects: 126

Group type: COMPARATOR
Intervention: Control (no platelet pheresis, n = 52)
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: PRPc (n = 10)
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: BBP (Blood Bank Platelets)
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: PRP+
Number of subjects: 126
Study: 2650586

Group type: EXPERIMENTAL
Intervention: Ketotifen capsule
Number of subjects: 305

Group type: COMPARATOR
Intervention: Clemastine tablet
Number of subjects: 305
Study: 687051

Group type: EXPERIMENTAL
Intervention: Diapulse
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Curapuls
Number of subjects: 300

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 300
Study: 30918997

Group type: EXPERIMENTAL
Intervention: Arthroscopic repair of lateral ankle ligament complex
Number of subjects: 0

Group type: COMPARATOR
Intervention: Open repair of lateral ankle ligament complex
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Arthroscopic treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Open surgery
Number of subjects: 0
Study: 28695477

Group type: EXPERIMENTAL
Intervention: Combined treatment of xylometazoline and dexpanthenol
Number of subjects: 152

Group type: COMPARATOR
Intervention: Xylometazoline monotherapy
Number of subjects: 152
Study: 26043895

Group type: EXPERIMENTAL
Intervention: Biodegradable polymer sirolimus-eluting stents (BP-SES)
Number of subjects: 486

Group type: COMPARATOR
Intervention: Durable polymer everolimus-eluting stents (DP-EES)
Number of subjects: 486
Study: 23859719

Group type: EXPERIMENTAL
Intervention: Declines in midarm circumference (MAC)
Number of subjects: 1846

Group type: EXPERIMENTAL
Intervention: Declines in skinfold measurements
Number of subjects: 1846

Group type: EXPERIMENTAL
Intervention: Declines in MAC and skinfold measurements in patients with BMI ≤25 kg/m2
Number of subjects: 1846
Study: 21679262

Group type: EXPERIMENTAL
Intervention: Psychiatric disorders
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Mood disorders
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Anxiety disorders
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Psychotic disorders
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Antisocial personality disorder
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Substance use disorders (SUDs)
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Psychiatric medications
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: HCV treatment eligibility
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Beck Depression Inventory
Number of subjects: 111
Study: 21179917

Group type: EXPERIMENTAL
Intervention: Evening (at bedtime) administration of Prestarium (perindopril) 10 mg, Tarka (180 mg verapamil hydrochloride/2 mg trandolapril), Norvasc (amlodipine besilat) 10 mg
Number of subjects: 60

Group type: COMPARATOR
Intervention: Morning (at awakening) administration of Prestarium (perindopril) 10 mg, Tarka (180 mg verapamil hydrochloride/2 mg trandolapril), Norvasc (amlodipine besilat) 10 mg
Number of subjects: 60
Study: 17338681

Group type: EXPERIMENTAL
Intervention: Living fibroblasts (20 million/mL)
Number of subjects: 215

Group type: COMPARATOR
Intervention: Placebo (transport medium without living cells)
Number of subjects: 215
Study: 15957201

Group type: EXPERIMENTAL
Intervention: Integrated housing services
Number of subjects: 121

Group type: COMPARATOR
Intervention: Parallel housing services
Number of subjects: 121
Study: 12131885

Group type: EXPERIMENTAL
Intervention: Sterile water irrigation with One-Step bonding agent
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 0.9% NaCl irrigation with One-Step bonding agent
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Filtered water irrigation with One-Step bonding agent
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Normal saline irrigation with One-Step bonding agent
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Normal saline irrigation with Solo bonding agent
Number of subjects: 40

Group type: COMPARATOR
Intervention: Tap water irrigation (control) with all bonding agents
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Sterile water irrigation with Prime & Bond or Single Bond Adhesive
Number of subjects: 40
Study: 9541523

Group type: EXPERIMENTAL
Intervention: Increased dietary phylloquinone to 420 microg/day with fortified corn oil, split between lunch and dinner meals.
Number of subjects: 9

Group type: COMPARATOR
Intervention: Mixed diet containing 100 microg of phylloquinone (baseline).
Number of subjects: 9
Study: 8004880

Group type: EXPERIMENTAL
Intervention: rFVIIa 17.5 micrograms/kg
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: rFVIIa 35 micrograms/kg
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: rFVIIa 70 micrograms/kg
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: rFVIIa
Number of subjects: 15
Study: 2681610

Group type: EXPERIMENTAL
Intervention: Hylan fluid (viscoelastic solution)
Number of subjects: 55
Study: 29396219

Group type: COMPARATOR
Intervention: Active control (household visits to measure mid-upper-arm circumference)
Number of subjects: 8246

Group type: EXPERIMENTAL
Intervention: Nutrition intervention (counselling on appropriate maternal, infant, and young child feeding plus small-quantity lipid-based nutrient supplements from 6-24 months)
Number of subjects: 8246

Group type: EXPERIMENTAL
Intervention: Combined water, sanitation, handwashing, and nutrition intervention
Number of subjects: 8246

Group type: EXPERIMENTAL
Intervention: Water intervention
Number of subjects: 8246

Group type: EXPERIMENTAL
Intervention: Sanitation intervention
Number of subjects: 8246

Group type: EXPERIMENTAL
Intervention: Handwashing intervention
Number of subjects: 8246

Group type: EXPERIMENTAL
Intervention: Combined water, sanitation, and handwashing intervention
Number of subjects: 8246
Study: 27181576

Group type: EXPERIMENTAL
Intervention: ipragliflozin
Number of subjects: 0

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 0
Study: 25786484

Group type: EXPERIMENTAL
Intervention: Passive heat stress
Number of subjects: 29
Study: 23833856

Group type: EXPERIMENTAL
Intervention: Xylocaine
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Remifentanil
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Fentanyl
Number of subjects: 200

Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 200
Study: 19442970

Group type: EXPERIMENTAL
Intervention: Educational DVD
Number of subjects: 131

Group type: COMPARATOR
Intervention: Educational brochure
Number of subjects: 131
Study: 18371481

Group type: EXPERIMENTAL
Intervention: Pioglitazone
Number of subjects: 5238

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5238
Study: 16022925

Group type: EXPERIMENTAL
Intervention: Nicotine replacement therapy (NRT)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Placebo patch
Number of subjects: 94
Study: 12692460

Group type: EXPERIMENTAL
Intervention: Conventional acupuncture
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Electro-acupuncture at 2 Hz
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Electro-acupuncture at 20 Hz
Number of subjects: 18

Group type: COMPARATOR
Intervention: Direct visual stimulation
Number of subjects: 18
Study: 10553483

Group type: EXPERIMENTAL
Intervention: Chronic low back pain patients (CBP)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Tension headache patients (THA)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Healthy controls (HC)
Number of subjects: 60
Study: 8534483

Group type: EXPERIMENTAL
Intervention: Inhaled beclomethasone dipropionate (BDP) 500 micrograms twice daily for 4 months
Number of subjects: 0

Group type: COMPARATOR
Intervention: Matched placebo for 4 months
Number of subjects: 0
Study: 1810682

Group type: EXPERIMENTAL
Intervention: Captopril 25 mg sublingually after 1 hour of nitroglycerin (3 mg/h) and heparin (1200 IU/h) infusion
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 7069074

Group type: EXPERIMENTAL
Intervention: Amoxicillin
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Trimethoprim-sulfamethoxazole
Number of subjects: 84

Group type: COMPARATOR
Intervention: Erythromycin
Number of subjects: 84

Group type: COMPARATOR
Intervention: Antihistamine decongestant (carbinoxamine maleate-pseudoephedrine HCl)
Number of subjects: 84
Study: 30633040

Group type: EXPERIMENTAL
Intervention: Injectable products (injection every 2-3 months)
Number of subjects: 536

Group type: EXPERIMENTAL
Intervention: Daily oral tablet
Number of subjects: 536

Group type: EXPERIMENTAL
Intervention: Monthly injections
Number of subjects: 536

Group type: EXPERIMENTAL
Intervention: Monthly ring
Number of subjects: 536

Group type: EXPERIMENTAL
Intervention: Multipurpose prevention technologies (combining HIV and pregnancy protection)
Number of subjects: 536
Study: 29162058

Group type: EXPERIMENTAL
Intervention: Cognitive rehabilitation therapy (CRT)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Mindfulness-based cognitive therapy (MBCT)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Enhanced treatment as usual (ETAU)
Number of subjects: 120
Study: 27991419

Group type: EXPERIMENTAL
Intervention: Comet
Number of subjects: 961

Group type: EXPERIMENTAL
Intervention: Incredible Years (IY)
Number of subjects: 961

Group type: EXPERIMENTAL
Intervention: Cope
Number of subjects: 961

Group type: EXPERIMENTAL
Intervention: Bibliotherapy
Number of subjects: 961

Group type: COMPARATOR
Intervention: Connect
Number of subjects: 961

Group type: COMPARATOR
Intervention: Cost-effectiveness analysis
Number of subjects: 961

Group type: EXPERIMENTAL
Intervention: Cost-effectiveness of Comet
Number of subjects: 961

Group type: EXPERIMENTAL
Intervention: Secondary analyses
Number of subjects: 961
Study: 25122448

Group type: EXPERIMENTAL
Intervention: Participants with past direct-personal trauma
Number of subjects: 65

Group type: COMPARATOR
Intervention: Participants without past direct-personal trauma
Number of subjects: 65
Study: 21924396

Group type: EXPERIMENTAL
Intervention: Dinoprostone followed 6 hours later by oxytocin infusion
Number of subjects: 450

Group type: COMPARATOR
Intervention: Oxytocin infusion
Number of subjects: 450
Study: 19152338

Group type: EXPERIMENTAL
Intervention: Coping-focused group intervention
Number of subjects: 235

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 235
Study: 17606658

Group type: EXPERIMENTAL
Intervention: Olanzapine (2.5-20 mg/day)
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Quetiapine (100-800 mg/day)
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Risperidone (0.5-4 mg/day)
Number of subjects: 400
Study: 16234442

Group type: COMPARATOR
Intervention: Latanoprost 0.005% at night
Number of subjects: 167

Group type: EXPERIMENTAL
Intervention: 360 degrees SLT
Number of subjects: 167

Group type: EXPERIMENTAL
Intervention: 180 degrees SLT
Number of subjects: 167

Group type: EXPERIMENTAL
Intervention: 90 degrees SLT
Number of subjects: 167
Study: 12039111

Group type: EXPERIMENTAL
Intervention: Misoprostol (up to two 800 microg doses vaginally)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50